Website & contact details
- Group website
- The site of this company’s group or brand.
Radnor Road Management Company Limited
- Incorporated
- 9 January 1986 (40 years)
- Industry
- Dormant Company (99999)
- Directors
- Owned by
- Accounts type
- Dormant
- Region
- East Midlands
- Address
- Martin HouseGloucester CrescentWigstonLE18 4YF
Filing status
- Accounts due
- 31 December 2027
- Last accounts
- 31 March 2026
- Conf. stmt due
- 20 August 2027
- Last conf. stmt
- 6 August 2026
Officers 1 active
Officer details are public data from the Companies House register.
British
Born December 1973 (52)
Officer history (10 former)
1 January 2024
1 January 2024
4 May 2018
4 May 2018
Resigned Worth, Christine as Secretary
3 May 2018
3 October 2012
Resigned Walker, Raymond as Director
3 October 2012
Resigned Walker, Raymond as Secretary
3 October 2012
Appointed Worth, Christine as Secretary
31 August 2005
11 November 2004
Appointed Walker, Raymond as Director
11 November 2004
Appointed Walker, Raymond as Secretary
11 November 2004
11 November 2004
Resigned Martin, Roger as Secretary
11 November 2004
Resigned Martin, Roger as Director
1 January 1992
Appointed Martin, Roger as Secretary
1 January 1992
1 January 1992
Resigned Hall, Kenneth Arthur as Secretary
1 January 1992
Resigned Hall, Kenneth Arthur as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 23 February 2018
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Limited Company
Reg. no. 06600162
Former controllers (1)
4 May 2018
Group structure 10 companies
Ownership group derived from the Companies House PSC register
Nova Bio-Pharma Holdings Limited Right to appoint and remove directors (as a firm)
Martin House Properties Limited Owns 75–100% of shares
Radnor Road Management Company Limited This company Owns 75–100% of shares
Nova Advanced Tissue Engineering Limited Owns 75–100% of shares (as a firm)
Nova Bio-Pharma Product Development Ltd Owns 75–100% of shares
Nova Bio-Pharma Technologies Limited Owns 75–100% of shares
Nova Immunotherapeutics Limited Owns 75–100% of shares
Nova Laboratories Limited Owns 75–100% of shares
Nova Primary Manufacturing Limited Owns 75–100% of shares (as a firm)
Financials
Balance sheet as at 31 March 2026 · dormant accounts · dormant
Trend
Shareholder Funds
Balance sheet detail
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Current Assets | £11 | £11 | £11 | £11 | £11 | £11 |
| Net Current Assets | £11 | £11 | £11 | £11 | £11 | |
| Shareholder Funds | £11 | £11 | £11 | £11 | £11 | £11 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 6 August 2026 | Confirmation statement with no updates | 6 August 2026 | ||
| 1 May 2026 | Accounts for a dormant company | 31 March 2026 | ||
| 8 August 2025 | Confirmation statement with updates | 6 August 2025 | ||
| 6 May 2025 | Accounts for a dormant company | 31 March 2025 | ||
| 12 August 2024 | Current accounting period extended |
Other companies in this industry
Rotherham
Lutterworth
London
Beckenham
Falkirk
Knutsford
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →